Becton, Dickinson and Company BDX Interventional — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Becton, Dickinson and Company's interventional — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Becton, Dickinson and Company's interventional — goodwill?
- Becton, Dickinson and Company (BDX) reported interventional — goodwill of $12.76B in Q1 2026.
- How has Becton, Dickinson and Company's interventional — goodwill changed year-over-year?
- Becton, Dickinson and Company's interventional — goodwill increased by 0.5% year-over-year, from $12.69B to $12.76B.
- What is the long-term trend for Becton, Dickinson and Company's interventional — goodwill?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's interventional — goodwill has grown at a -0.1% compound annual growth rate (CAGR), from $51.11B to $50.87B.
- What does interventional — goodwill mean?
- This metric represents the excess purchase price paid for acquisitions within the Interventional segment over the fair value of the identifiable net assets acquired. It serves as a balance sheet indicator of the premium paid for market share, synergies, and intellectual property in the interventional medical space. Significant changes in this balance typically reflect recent M&A activity or impairment charges.